diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: intervention group: 15 grams of powdered fenugreek seeds in doses of 5 grams three times a day between meals, dissolved in water for 8 weeks. Intervention 2: control group: no action.
Treatment - Other
control group: no action
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: voluntary participation; At least 1 year and a maximum of 10 years diabetes history and observing at least 6 months diabetic diet; taking oral drugs lowering blood glucose to control diabetes; 18 to 65 years old; Lack of pregnancy and lactation; Not having certain diseases (liver, kidney, heart, thyroid, rheumatoid, respiratory, metabolic, gastrointestinal, malignancy, allergic diseases); no need for insulin; not using dietary, vitamin and mineral supplements, at least three months before the study; not hormone therapy; no smoking; no using other medicinal plants routinely, at least 3 months prior to the study exclusion criteria: unwillingness to continue; developing specific diseases (liver, kidney, heart, thyroid, rheumatoid, respiratory, metabolic, gastrointestinal, malignancy, allergic diseases) during the study; starting pregnancy and lactation; starting insulin therapy; starting using dietary, vitamin and mineral supplements; change in the dose of oral blood glucose lowering drugs; Change in the physical activity during the study; start taking other medicinal plants routinely
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HDL. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;LDL. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;Total cholestrol. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;Triglyceride. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;Irisin. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;Fasting glucose. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;2hppg. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;HbA1C. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of blood level.;Insulin. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;VLDL. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: formula calculation. | — |
Secondary
| Measure | Time frame |
|---|---|
| HOMA-IR. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: formula calculation.;HOMA-B. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: formula calculation.;QUICKI. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: formula calculation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRahele Tavakoly
School of Nutrition and Food Sciences, Isfahan University of Medical Sciences
Outcome results
None listed